Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2010
11/03/2010CN101878027A Receptor targeting ligands
11/03/2010CN101875631A Dye composition
11/03/2010CN101875627A 1-carbalkoxy-2H-isoindazole derivative, preparation method and intermediate thereof
11/03/2010CN101052617B Process for the preparation of alkyl 5-(dicarboximido)levulinate and alkyl 4-oxo-pentenoate
11/02/2010US7825263 Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive
11/02/2010US7825262 heating the tetrahydronaphthalic anhydride with a reagent mixture comprising ammonium nitrate; cost efficiency
11/02/2010US7825155 Oxindole derivative as feeding control agent
11/02/2010US7825152 Organic compounds and their uses
11/02/2010CA2485201C Camptothecins with a modified lactone ring
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010124047A1 Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mglur5)
10/28/2010WO2010123139A1 Arylcarboxamide derivative having sulfamoyl group
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010WO2010122343A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/28/2010WO2010121382A1 Process for making indole cyclopropyl amide derivatives
10/28/2010WO2009127338A8 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/28/2010US20100274051 Inflammatory cytokine release inhibitor
10/28/2010US20100274026 Virus therapeutic drug
10/28/2010US20100274025 Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereof
10/28/2010US20100274024 A Compound Absorbing Sunlight And Converting The Sunlight Into Electrical Energy, And Method For Manufacturing The Same
10/28/2010US20100274023 Novel intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
10/28/2010US20100273853 Novel isoindol derivatives as ep4 receptor agonists
10/28/2010US20100273850 4-heteroaryl-substituted phenoxyphenylacetic acid derivatives
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273776 Inhibition of alpha-synuclein toxicity
10/28/2010US20100273772 Bisaryl Alkynylamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5 (MGLUR5)
10/28/2010US20100273763 Organometallic complexes as therapeutic agents
10/28/2010US20100273724 Pegylated ion channel modulating compounds
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/28/2010CA2756876A1 A process for the preparation of frovatriptan and frovatriptan succinate and their synthetic intermediates
10/27/2010EP2243772A1 Novel P2X7R antagonists and their use
10/27/2010EP2242740A1 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
10/27/2010EP1383742B1 Synthesis and methods of use of tetrahydroindolone analogues and derivatives
10/27/2010CN101874019A Preparation of dihydropyrrol derivatives as intermediates
10/27/2010CN101870761A Optical rotation polyurethane-imide infrared low-emissivity material and preparation method thereof
10/27/2010CN101870705A Novel organic compound, light-emitting device, and image display apparatus
10/27/2010CN101870696A N-aryl piperazine derivative having double activity of dopamine D2 and 5-HT2a
10/27/2010CN101307019B Method for preparing N-amino-3-azabicyclo[3,3,0]octane hydrochloride
10/27/2010CN101027306B Method of preparing poly(ADP-ribose) polymerases inhibitors
10/26/2010US7820858 Reacting aldehyde with iminium ion via Mannich reaction to yield alpha substituted beta amino aldehyde; reducing in situ to alcohol form then oxidizing to carboxylic acid; industrial scale, easy purification; chemical intermediates
10/26/2010US7820831 Compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of α-perfluoroalkylamine compounds
10/26/2010US7820824 As labeling reagents for a variety of biological applications
10/26/2010US7820783 Contain chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and 3'-position, their bioconjugates
10/26/2010US7820671 Peptidomimetic protease inhibitors
10/21/2010WO2010120935A1 Anti-viral compounds
10/21/2010WO2010120398A2 Process for preparing n-substituted cyclic imides
10/21/2010WO2010120058A2 Novel cyanine compound for labelling biomolecules, and preparation method thereof
10/21/2010WO2010119992A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010WO2010119984A1 3-aryl or heteroaryl-substituted indole derivative
10/21/2010WO2010118997A1 Processes for the synthesis of bazedoxifene acetate and intermediates thereof
10/21/2010WO2010118921A1 Novel p2x7r antagonists and their use
10/21/2010WO2010118757A1 Improved process for the preparation of fluvastatin and salts thereof
10/21/2010US20100267962 N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form anti-allergic, anti-inflammatory and hypolipidemic agents
10/21/2010US20100267937 Cyanine Dye Labelling Reagents
10/21/2010US20100267800 N-Alkyl-Hydroxamic Acid-Isoindolyl Compounds and Their Pharmaceutical Uses
10/21/2010US20100267798 Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
10/21/2010US20100267762 Novel p2x7r antagonists and their use
10/21/2010US20100267754 Integrin expression inhibitor
10/21/2010US20100267726 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267008 Chiral indole intermediates and their fluorescent cyanine dyes containing functional groups
10/21/2010CA2758895A1 Derivatives of n-acyl-n'-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/21/2010CA2758484A1 Anti-viral compounds
10/21/2010CA2758109A1 Processes for the synthesis of bazedoxifene acetate and intermediates thereof
10/20/2010EP2240446A2 Carbazole-containing materials in phosphorescent light emitting diodes
10/20/2010EP2240445A1 Novel salt of tegaserod
10/20/2010EP2240444A1 Compounds having crth2 antagonist activity
10/20/2010EP2240029A1 Compounds for inflammation and immune-related uses
10/20/2010EP2240016A1 Ampk modulators
10/20/2010EP1948166B1 Carbazole derivatives as functional 5-ht6 ligands
10/20/2010EP1899299B1 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
10/20/2010EP1308438B1 3-substituted urea derivatives and medicinal use thereof
10/20/2010CN101868444A Acetylene compound, salt thereof, condensate thereof, and composition thereof
10/20/2010CN101868233A Combination therapy related to serotonin dual action compounds
10/20/2010CN101863824A Synthesis method of chemical compound containing a dihydrogen ferrocenylmethyl-substituted indenes ketone and pyrrole skeleton
10/20/2010CN101863823A 2-oxindole compounds, and ring-enlargement derivatives, preparation method and application thereof
10/20/2010CN101863822A Production method for extracting tryptophan from fermentation liquor by one-step refining
10/20/2010CN101863794A 3'-alkoxy spirocyclische tetramic and tetronic acids
10/20/2010CN101863727A Method for preparing amino acid by hydrolyzing soybean dregs in near-critical water
10/19/2010US7816542 Compounds and compositions as TPO mimetics
10/19/2010US7816541 Process for producing an optically active compound
10/19/2010US7816536 4-substituted and 7-substituted indoles, benzofurans, benzothiophenes, benzimidazoles, benzoxazoles, and benzothiazoles and methods for making same
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816408 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
10/19/2010US7816393 phosphodiesterase 4 inhibitors such as 4-Carbamoyl-4-{4-[(furan-2-yl-methylamino]-1,3-dioxo 1,3-dihydro-isoindol-2-yl}-butyric acid for treatment of cancer; immunotherapy
10/19/2010US7816386 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumor agents
10/19/2010CA2464367C Bicyclic compounds
10/19/2010CA2409743C Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
10/19/2010CA2380022C Aromatic esters of camptothecins and methods to treat cancers
10/19/2010CA2362715C Quinazoline derivatives as angiogenesis inhibitors
10/19/2010CA2321455C Indole-3-propionic acids, salts and esters thereof used as medicaments
10/14/2010WO2010117085A1 Aryl indole derivatives
10/14/2010WO2010116248A1 Organic compounds and their uses
10/14/2010WO2010115974A1 Crystal forms of saxagliptin
10/14/2010WO2010115736A2 Dihydroorotate dehydrogenase inhibitors
10/14/2010WO2010115252A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/14/2010WO2010089778A3 Process for the synthesis of cleistanthin
10/14/2010WO2009044019A9 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
10/14/2010US20100261903 Phosphonate fluorescent dyes and conjugates
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 458